289 related articles for article (PubMed ID: 25376267)
1. Randomized, double-blind trial of anidulafungin versus fluconazole for prophylaxis of invasive fungal infections in high-risk liver transplant recipients.
Winston DJ; Limaye AP; Pelletier S; Safdar N; Morris MI; Meneses K; Busuttil RW; Singh N
Am J Transplant; 2014 Dec; 14(12):2758-64. PubMed ID: 25376267
[TBL] [Abstract][Full Text] [Related]
2. Targeted versus universal antifungal prophylaxis among liver transplant recipients.
Eschenauer GA; Kwak EJ; Humar A; Potoski BA; Clarke LG; Shields RK; Abdel-Massih R; Silveira FP; Vergidis P; Clancy CJ; Nguyen MH
Am J Transplant; 2015 Jan; 15(1):180-9. PubMed ID: 25359455
[TBL] [Abstract][Full Text] [Related]
3. Antifungal prophylaxis in liver transplantation: a systematic review and network meta-analysis.
Evans JD; Morris PJ; Knight SR
Am J Transplant; 2014 Dec; 14(12):2765-76. PubMed ID: 25395336
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic fluconazole in liver transplant recipients. A randomized, double-blind, placebo-controlled trial.
Winston DJ; Pakrasi A; Busuttil RW
Ann Intern Med; 1999 Nov; 131(10):729-37. PubMed ID: 10577295
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of anti-fungal agents for invasive fungal infection prophylaxis in liver transplant recipients: A network meta-analysis.
Liu Y; Lan C; Qin S; Qin Z; Zhang Z; Zhang P; Cao W
Mycoses; 2022 Oct; 65(10):906-917. PubMed ID: 35899464
[TBL] [Abstract][Full Text] [Related]
6. Antifungal agents for preventing fungal infections in solid organ transplant recipients.
Playford EG; Webster AC; Sorell TC; Craig JC
Cochrane Database Syst Rev; 2004; (3):CD004291. PubMed ID: 15266524
[TBL] [Abstract][Full Text] [Related]
7. Revisiting antifungal prophylaxis in high-risk liver transplant recipients.
Huprikar S
Am J Transplant; 2014 Dec; 14(12):2683-4. PubMed ID: 25376442
[No Abstract] [Full Text] [Related]
8. Safety of anidulafungin in solid organ transplant recipients.
Aguado JM; Varo E; Usetti P; Pozo JC; Moreno A; Catalán M; Len O; Blanes M; Solé A; Muñoz P; Montejo M;
Liver Transpl; 2012 Jun; 18(6):680-5. PubMed ID: 22328277
[TBL] [Abstract][Full Text] [Related]
9. A Multicenter, Randomized, Open-Label Study to Compare Micafungin with Fluconazole in the Prophylaxis of Invasive Fungal Infections in Living-Donor Liver Transplant Recipients.
Kang WH; Song GW; Lee SG; Suh KS; Lee KW; Yi NJ; Joh JW; Kwon CHD; Kim JM; Choi DL; Kim JD; Kim MS
J Gastrointest Surg; 2020 Apr; 24(4):832-840. PubMed ID: 31066013
[TBL] [Abstract][Full Text] [Related]
10. Invasive fungal infections following liver transplantation: incidence, risk factors, survival, and impact of fluconazole-resistant Candida parapsilosis (2003-2007).
Raghuram A; Restrepo A; Safadjou S; Cooley J; Orloff M; Hardy D; Butler S; Koval CE
Liver Transpl; 2012 Sep; 18(9):1100-9. PubMed ID: 22577087
[TBL] [Abstract][Full Text] [Related]
11. Caspofungin versus fluconazole as prophylaxis of invasive fungal infection in high-risk liver transplantation recipients: A propensity score analysis.
Fortún J; Muriel A; Martín-Dávila P; Montejo M; Len O; Torre-Cisneros J; Carratalá J; Muñoz P; Fariñas C; Moreno A; Fresco G; Goikoetxea J; Gavaldá J; Pozo JC; Bodro M; Vena A; Casafont F; Cervera C; Silva JT; Aguado JM;
Liver Transpl; 2016 Apr; 22(4):427-35. PubMed ID: 26709146
[TBL] [Abstract][Full Text] [Related]
12. Antifungal prophylaxis in liver transplant recipients: one size does not fit all.
Giannella M; Bartoletti M; Morelli M; Cristini F; Tedeschi S; Campoli C; Tumietto F; Bertuzzo V; Ercolani G; Faenza S; Pinna AD; Lewis RE; Viale P
Transpl Infect Dis; 2016 Aug; 18(4):538-44. PubMed ID: 27237076
[TBL] [Abstract][Full Text] [Related]
13. Randomized controlled trial of oral itraconazole solution versus intravenous/oral fluconazole for prevention of fungal infections in liver transplant recipients.
Winston DJ; Busuttil RW
Transplantation; 2002 Sep; 74(5):688-95. PubMed ID: 12352887
[TBL] [Abstract][Full Text] [Related]
14. Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta-analysis.
Gatti M; Rinaldi M; Ferraro G; Toschi A; Caroccia N; Arbizzani F; Raschi E; Poluzzi E; Pea F; Viale P; Giannella M
Mycoses; 2021 Nov; 64(11):1317-1327. PubMed ID: 34387004
[TBL] [Abstract][Full Text] [Related]
15. Randomized trial of micafungin versus fluconazole as prophylaxis against invasive fungal infections in hematopoietic stem cell transplant recipients.
Park S; Kim K; Jang JH; Kim SJ; Kim WS; Chung DR; Kang CI; Peck KR; Jung CW
J Infect; 2016 Nov; 73(5):496-505. PubMed ID: 27394404
[TBL] [Abstract][Full Text] [Related]
16. [Role of anidulafungin in solid organ transplant recipients].
Aguado JM; Ayats J
Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 14():29-34. PubMed ID: 19572432
[TBL] [Abstract][Full Text] [Related]
17. Randomized trial of micafungin for the prevention of invasive fungal infection in high-risk liver transplant recipients.
Saliba F; Pascher A; Cointault O; Laterre PF; Cervera C; De Waele JJ; Cillo U; Langer RM; Lugano M; Göran-Ericzon B; Phillips S; Tweddle L; Karas A; Brown M; Fischer L; ;
Clin Infect Dis; 2015 Apr; 60(7):997-1006. PubMed ID: 25520332
[TBL] [Abstract][Full Text] [Related]
18. Universal prophylaxis with fluconazole for the prevention of early invasive fungal infection in low-risk liver transplant recipients.
San-Juan R; Aguado JM; Lumbreras C; Fortun J; Len O; Muñoz P; Montejo M; Moreno A; Cordero E; Blanes M; Ramos A; de la Torre-Cisneros J; Lopez-Medrano F; Carratala J; Moreno E;
Transplantation; 2011 Aug; 92(3):346-50. PubMed ID: 21709604
[TBL] [Abstract][Full Text] [Related]
19. A retrospective analysis of the use of caspofungin in recipients of liver transplant with a modified high index of suspicion for fungal infection. A critical review of mortality, acute cellular rejection, infections, and changes in the liver function tests while on caspofungin.
Doria C; Bodzin AS; Vaccino S; Daskalakis C; Krawitz S; Ramirez CB
Clin Transplant; 2011; 25(4):569-75. PubMed ID: 20662881
[TBL] [Abstract][Full Text] [Related]
20. Clinical efficacy and safety of primary antifungal prophylaxis with posaconazole versus fluconazole in allogeneic blood hematopoietic stem cell transplantation recipients-A retrospective analysis of a single medical center in Taiwan.
Wang CH; Kan LP; Lin HA; Chang FY; Wang NC; Lin TY; Chao TY; Kao WY; Ho CL; Chen YC; Dai MS; Chang PY; Wu YY; Lin JC
J Microbiol Immunol Infect; 2016 Aug; 49(4):531-8. PubMed ID: 25440977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]